Zobrazeno 1 - 10
of 920
pro vyhledávání: '"Buhl DL"'
Autor:
Herzog R; Latin American Brain Health Institute, Universidad Adolfo Ibañez, Santiago de Chile, Chile. ruben.herzog@icm-institute.org.; Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Paris, France. ruben.herzog@icm-institute.org., Barbey FM; Cumulus Neuroscience Ltd, Dublin, Ireland., Islam MN; Cumulus Neuroscience Ltd, Dublin, Ireland., Rueda-Delgado L; Cumulus Neuroscience Ltd, Dublin, Ireland., Nolan H; Cumulus Neuroscience Ltd, Dublin, Ireland., Prado P; Escuela de Fonoaudiología, Facultad de Odontología y Ciencias de la Rehabilitación, Universidad San Sebastián, Santiago, Chile., Krylova M; Department of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany., Izyurov I; Department of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany., Javaheripour N; Department of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany., Danyeli LV; Department of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany., Sen ZD; Department of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany., Walter M; Department of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany.; German Center for Mental Health (DZPG), partner site Halle-Jena-Magdeburg, Jena, Germany., O'Donnell P; Neuroscience Drug Discovery Unit, Takeda Pharmaceuticals, Cambridge, MA, 02390, USA., Buhl DL; Neuroscience Drug Discovery Unit, Takeda Pharmaceuticals, Cambridge, MA, 02390, USA., Murphy B; Cumulus Neuroscience Ltd, Dublin, Ireland., Ibanez A; Latin American Brain Health Institute, Universidad Adolfo Ibañez, Santiago de Chile, Chile. agustin.ibanez@gbhi.org.; Global Brain Health Institute, UCSF and Trinity College Dublin, Dublin, Ireland. agustin.ibanez@gbhi.org.
Publikováno v:
Translational psychiatry [Transl Psychiatry] 2024 Jul 27; Vol. 14 (1), pp. 310. Date of Electronic Publication: 2024 Jul 27.
Autor:
Tracey B; Takeda Development Center Americas, Inc., Lexington, MA, USA., Culp M; Stat Tenacity, LLC, Saline, MI, USA., Fabregas S; Signal Insights, LLC, Cambridge, MA, USA., Mignot E; Stanford Department of Psychiatry and Behavioral Sciences, Center for Sleep Sciences and Medicine, Stanford University Medical School, Palo Alto, CA, USA., Buhl DL; Takeda Development Center Americas, Inc., Lexington, MA, USA., Volfson D; Takeda Development Center Americas, Inc., Lexington, MA, USA.
Publikováno v:
Sleep [Sleep] 2024 Jul 02. Date of Electronic Publication: 2024 Jul 02.
Autor:
O'Donnell P; Translational Medicine, Alto Neuroscience, Mountain View, CA, USA. podonnell@altoneuroscience.com., Buhl DL; Precision Medicine, Abbvie, Inc, Cambridge, MA, USA., Johannesen J; Translational Medicine, Sage Therapeutics, Cambridge, MA, USA., Lijffijt M; Sama Therapeutics, Cambridge, MA, USA.
Publikováno v:
Advances in neurobiology [Adv Neurobiol] 2024; Vol. 40, pp. 45-65.
Autor:
Vilela M; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, USA., Tracey B; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, USA., Volfson D; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, USA., Barateau L; Department of Neurology, Sleep-Wake Disorders Center, Gui-de-Chauliac Hospital, CHU, Montpellier, France.; National Reference Network for Narcolepsy, Montpellier, France.; Institute for Neurosciences of Montpellier (INM), INSERM, University of Montpellier, Montpellier, France., Cai A; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, USA., Buhl DL; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, USA., Dauvilliers Y; Department of Neurology, Sleep-Wake Disorders Center, Gui-de-Chauliac Hospital, CHU, Montpellier, France.; National Reference Network for Narcolepsy, Montpellier, France.; Institute for Neurosciences of Montpellier (INM), INSERM, University of Montpellier, Montpellier, France.
Publikováno v:
Journal of sleep research [J Sleep Res] 2024 Apr 26, pp. e14216. Date of Electronic Publication: 2024 Apr 26.
Autor:
O'Donnell P; Takeda Pharmaceuticals USA, Inc, Cambridge, MA, USA. patricio.odonnell@sagerx.com.; McLean Hospital, Department of Psychiatry, Harvard Medical School, Boston, MA, USA. patricio.odonnell@sagerx.com., Dong C; Takeda Pharmaceuticals USA, Inc, Cambridge, MA, USA., Murthy V; Takeda Pharmaceuticals USA, Inc, Cambridge, MA, USA., Asgharnejad M; Takeda Pharmaceuticals USA, Inc, Cambridge, MA, USA., Du X; Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA., Summerfelt A; Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA., Lu H; Takeda Pharmaceuticals USA, Inc, Cambridge, MA, USA., Xu L; Takeda Pharmaceuticals USA, Inc, Cambridge, MA, USA., Wendland JR; Takeda Pharmaceuticals USA, Inc, Cambridge, MA, USA., Dunayevich E; Neurocrine Biosciences, Inc., San Diego, CA, USA., Buhl DL; Takeda Pharmaceuticals USA, Inc, Cambridge, MA, USA., Litman R; CBH Health, Gaithersburg, MD, USA., Hetrick WP; Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, USA., Hong LE; Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA., Rosen LB; Takeda Pharmaceuticals USA, Inc, Cambridge, MA, USA.
Publikováno v:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2023 Jun; Vol. 48 (7), pp. 1052-1059. Date of Electronic Publication: 2023 Mar 16.
Autor:
Cecchi M; Cognision, KY, USA. Electronic address: mcecchi@cognision.com., Adachi M; Astellas Pharma, CA, USA., Basile A; Merck & Co., Inc., Kenilworth, NJ, USA., Buhl DL; Takeda Pharmaceuticals, MA, USA., Chadchankar H; Novartis, MA, USA., Christensen S; Lundbeck, Denmark., Christian E; Gilgamesh Pharmaceuticals, NY, USA., Doherty J; Sage Therapeutics, MA, USA., Fadem KC; Cognision, KY, USA., Farley B; Sage Therapeutics, MA, USA., Forman MS; Passage Bio, PA, USA., Honda S; Astellas Pharma, CA, USA., Johannesen J; Sage Therapeutics, MA, USA., Kinon BJ; Cyclerion Therapeutics, MA, USA., Klamer D; Anavex Life Sciences Corp., NY, USA., Marino MJ; Merck & Co., Inc., Kenilworth, NJ, USA., Missling C; Anavex Life Sciences Corp., NY, USA., O'Donnell P; Sage Therapeutics, MA, USA., Piser T; Onsero Therapeutics, MA, USA., Puryear CB; Praxis Precision Medicines, MA, USA., Quirk MC; Sage Therapeutics, MA, USA., Rotte M; Novartis, MA, USA., Sanchez C; Alkermes, MA, USA., Smith DG; Alkermes, MA, USA., Uslaner JM; Merck & Co., Inc., Kenilworth, NJ, USA., Javitt DC; Columbia University, NY, USA., Keefe RSE; VeraSci, NC, USA., Mathalon D; University of California, San Francisco, CA, USA., Potter WZ; Independent Consultant, Philadelphia, PA, USA., Walling DP; CenExel Research, USA., Ereshefsky L; CenExel Research, USA; University of Texas Health Science Center at San Antonio, TX, USA.
Publikováno v:
Schizophrenia research [Schizophr Res] 2023 Apr; Vol. 254, pp. 178-189. Date of Electronic Publication: 2023 Mar 13.
Autor:
Yin W; Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA., Mamashli F; Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA.; Signal Insights, LLC, Cambridge, MA, USA., Buhl DL; Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA., Khudyakov P; Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA., Volfson D; Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA., Martenyi F; Prothena Biosciences, South San Francisco, CA, USA., Gevorkyan H; California Clinical Trials Medical Group, in affiliation with Parexel International, Glendale, CA, USA., Rosen L; Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA., Simen AA; Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2022 Feb; Vol. 88 (2), pp. 600-612. Date of Electronic Publication: 2021 Jul 31.
Autor:
O'Donnell P; Takeda Pharmaceuticals International, Inc., Cambridge, MA, USA. Patricio.odonnell@takeda.com.; McLean Hospital, Department of Psychiatry, Harvard Medical School, Belmont, MA, USA. Patricio.odonnell@takeda.com., Dijkstra FM; Centre for Human Drug Research (CHDR), Leiden, The Netherlands.; Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands., Damar U; Neuromodulation Program, Department of Neurology and F.M. Kirby Center for Neurobiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Quanhong L; Takeda Pharmaceuticals International, Inc., Cambridge, MA, USA., de Goede AA; Centre for Human Drug Research (CHDR), Leiden, The Netherlands., Xu L; Takeda Pharmaceuticals International, Inc., Cambridge, MA, USA., Pascual-Leone A; Neuromodulation Program, Department of Neurology and F.M. Kirby Center for Neurobiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Buhl DL; Takeda Pharmaceuticals International, Inc., Cambridge, MA, USA., Zuiker R; Centre for Human Drug Research (CHDR), Leiden, The Netherlands., Ruijs TQ; Centre for Human Drug Research (CHDR), Leiden, The Netherlands., Heuberger JAAC; Centre for Human Drug Research (CHDR), Leiden, The Netherlands., MacMullin P; Neuromodulation Program, Department of Neurology and F.M. Kirby Center for Neurobiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Lubell M; Takeda Pharmaceuticals International, Inc., Cambridge, MA, USA., Asgharnejad M; Takeda Pharmaceuticals International, Inc., Cambridge, MA, USA., Murthy V; Takeda Pharmaceuticals International, Inc., Cambridge, MA, USA., Rotenberg A; Neuromodulation Program, Department of Neurology and F.M. Kirby Center for Neurobiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Jacobs GE; Centre for Human Drug Research (CHDR), Leiden, The Netherlands.; Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands., Rosen L; Takeda Pharmaceuticals International, Inc., Cambridge, MA, USA.
Publikováno v:
Translational psychiatry [Transl Psychiatry] 2021 May 27; Vol. 11 (1), pp. 325. Date of Electronic Publication: 2021 May 27.
Autor:
Ahuis, Tim P.1,2 (AUTHOR), Smyk, Magdalena K.1,3 (AUTHOR), Laloux, Clément4 (AUTHOR), Aulehner, Katharina5 (AUTHOR), Bray, Jack6 (AUTHOR), Waldron, Ann-Marie5 (AUTHOR), Miljanovic, Nina5 (AUTHOR), Seiffert, Isabel5 (AUTHOR), Song, Dekun7 (AUTHOR), Boulanger, Bruno4 (AUTHOR), Jucker, Mathias8 (AUTHOR), Potschka, Heidrun5 (AUTHOR), Platt, Bettina6 (AUTHOR), Riedel, Gernot6 (AUTHOR), Voehringer, Patrizia2 (AUTHOR), Nicholson, Janet R.2 (AUTHOR), Drinkenburg, Wilhelmus H. I. M.1,3 (AUTHOR), Kas, Martien J. H.1 (AUTHOR) m.j.h.kas@rug.nl, Leiser, Steven C.7 (AUTHOR) stevenleiser@gmail.com
Publikováno v:
PLoS ONE. 10/29/2024, Vol. 19 Issue 10, p1-35. 35p.
Autor:
Lamberti, Martina1 (AUTHOR) m.lamberti@utwente.nl, Kikirikis, Nikolaos1 (AUTHOR), Putten, Michel J. A. M. van1 (AUTHOR), Feber, Joost le1 (AUTHOR) j.lefeber@utwente.nl
Publikováno v:
Scientific Reports. 10/10/2024, Vol. 14 Issue 1, p1-11. 11p.